Point72 Asset Management
FCSC

Point72 Asset Management’s Fibrocell Science Inc. FCSC Stock Holding History

Point72 Asset Management’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-80,000
Closed -$216K – 1325
2018
Q2 		$216K Hold
80,000
– – ﹤0.01% 905
2018
Q1 		$236K Buy
80,000
+40,000
+100% +$131K ﹤0.01% 876
2017
Q4 		$128K Buy
+40,000
New +$350K ﹤0.01% 873

Other funds holding FCSC

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Point72 Asset Management's FCSC Position: Q3 2018 in Review

Point72 Asset Management sold out of Fibrocell Science Inc. (FCSC) in Q3 2018, closing a stake of 80,000 shares — an estimated $216K sold.

Point72 Asset Management first reported a position in FCSC in Q4 2017 and held it in 3 quarters. The position peaked at $236K in Q1 2018. 25 funds tracked by Wall St. Rank hold FCSC as of Q3 2018.

  • Point72 Asset Management reported no remaining Fibrocell Science Inc. position as of Q3 2018 after selling out during the quarter.
  • Point72 Asset Management sold 80,000 Fibrocell Science Inc. shares in Q3 2018, an estimated $216K.
  • Point72 Asset Management first reported a position in Fibrocell Science Inc. in Q4 2017 and held it in 3 quarters.
  • Point72 Asset Management's Fibrocell Science Inc. position peaked at $236K in Q1 2018.
  • 25 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q3 2018.

Based on Point72 Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.